Literature DB >> 18949650

Pediatric fatality secondary to EDTA chelation.

Arla J Baxter1, Edward P Krenzelok.   

Abstract

BACKGROUND: Chelation therapy has emerged as a popular treatment modality to remove heavy metals that are thought to cause autism. We report a fatality that occurred as a consequence of chelation therapy for autism when the incorrect form of EDTA was administered. CASE REPORT: A five-year-old autistic male was being chelated in a physician's office. While receiving his third treatment he went into cardiac arrest. It was not determined until after the child's death that he had been given edetate disodium rather than edetate calcium disodium, causing profound hypocalcemia and triggering the cardiac events that led to his death. DISCUSSION: In 1991, the CDC recommended using only edetate calcium disodium, not edetate disodium, to children because edetate disodium may induce tetany and possible hypocalcemia as illustrated in this case.
CONCLUSION: The use of chelation therapy in autistic children has not been validated and can have tragic consequences.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18949650     DOI: 10.1080/15563650701261488

Source DB:  PubMed          Journal:  Clin Toxicol (Phila)        ISSN: 1556-3650            Impact factor:   4.467


  11 in total

1.  Emergence of autism spectrum disorder in children from simplex families: relations to parental perceptions of etiology.

Authors:  Robin P Goin-Kochel; Sarah S Mire; Allison G Dempsey
Journal:  J Autism Dev Disord       Date:  2015-05

Review 2.  Children With Autism Spectrum Disorder and Lead Poisoning: Diagnostic Challenges and Management Complexities.

Authors:  Marissa Hauptman; Bryan Stierman; Alan D Woolf
Journal:  Clin Pediatr (Phila)       Date:  2019-04-02       Impact factor: 1.168

3.  Commentary on the abuse of metal chelation therapy in patients with autism spectrum disorders.

Authors:  Jeffrey Brent
Journal:  J Med Toxicol       Date:  2013-12

Review 4.  A review of drug-induced hypocalcemia.

Authors:  George Liamis; Haralampos J Milionis; Moses Elisaf
Journal:  J Bone Miner Metab       Date:  2009       Impact factor: 2.626

Review 5.  Autism spectrum disorders.

Authors:  Hadeel Faras; Nahed Al Ateeqi; Lee Tidmarsh
Journal:  Ann Saudi Med       Date:  2010 Jul-Aug       Impact factor: 1.526

Review 6.  Clawing back: broadening the notion of metal chelators in medicine.

Authors:  Katherine J Franz
Journal:  Curr Opin Chem Biol       Date:  2013-01-17       Impact factor: 8.822

7.  An Update on Childhood Lead Poisoning.

Authors:  Marissa Hauptman; Rebecca Bruccoleri; Alan D Woolf
Journal:  Clin Pediatr Emerg Med       Date:  2017-09

8.  Correlates of genetic attributions among parents of children in the USA with developmental disabilities.

Authors:  Bridget Kiely; Sujit Vettam; Andrew Adesman
Journal:  Appl Clin Genet       Date:  2019-04-12

Review 9.  Evaluating Sensory Integration/Sensory Processing Treatment: Issues and Analysis.

Authors:  Stephen Camarata; Lucy Jane Miller; Mark T Wallace
Journal:  Front Integr Neurosci       Date:  2020-11-26

10.  Cu2+ selective chelators relieve copper-induced oxidative stress in vivo.

Authors:  Ananya Rakshit; Kaustav Khatua; Vinit Shanbhag; Peter Comba; Ankona Datta
Journal:  Chem Sci       Date:  2018-10-02       Impact factor: 9.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.